TEACHERS ADVISORS, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
TEACHERS ADVISORS, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$46,663,000
+276.4%
293,384
+126.7%
0.06%
+235.3%
Q4 2018$12,398,000
-70.0%
129,430
-55.7%
0.02%
-32.0%
Q3 2018$41,278,000
+68.4%
292,236
+86.6%
0.02%
-19.4%
Q2 2018$24,511,000
-37.0%
156,587
-35.2%
0.03%
-38.0%
Q1 2018$38,913,000
+71.6%
241,588
+75.5%
0.05%
+72.4%
Q4 2017$22,677,000
+183.5%
137,679
+7.2%
0.03%
+163.6%
Q3 2017$8,000,000
-23.1%
128,413
-1.7%
0.01%
-26.7%
Q2 2017$10,407,000
+24.0%
130,677
+10.7%
0.02%
+25.0%
Q1 2017$8,391,000
+233.4%
118,072
+139.5%
0.01%
+200.0%
Q4 2016$2,517,000
+27.5%
49,296
+15.0%
0.00%
+33.3%
Q3 2016$1,974,000
+52.8%
42,8770.0%0.00%
+50.0%
Q2 2016$1,292,000
+80.2%
42,877
+91.6%
0.00%
+100.0%
Q1 2016$717,000
-40.5%
22,373
+8.2%
0.00%
-50.0%
Q4 2015$1,206,000
+39.3%
20,679
+1.0%
0.00%0.0%
Q3 2015$866,000
-40.7%
20,474
+2.3%
0.00%
-33.3%
Q2 2015$1,461,000
+268.0%
20,015
+153.1%
0.00%
+200.0%
Q1 2015$397,000
+41.3%
7,909
+3.0%
0.00%0.0%
Q4 2014$281,000
+66.3%
7,681
+43.3%
0.00%
Q3 2014$169,0005,3600.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders